Arnold Holdings Buyback 2024 vs Zydus Lifesciences Buyback 2024

Comparision between Arnold Holdings Buyback 2024 and Zydus Lifesciences Buyback 2024.

Buyback Details

Arnold Holdings Buyback 2024 is a Tender Offer buyback proposed to list at BSE while Zydus Lifesciences Buyback 2024 is a Tender Offer proposed to list at BSE, NSE.

Arnold Holdings Limited

Zydus Lifesciences Limited

Logo

Type of Buyback

Tender Offer

Listing At

BSE

BSE, NSE

Face Value

₹10 per share

₹1 per share

Buyback Price

₹21 per share

₹1005 per share

Issue Size

63,00,000 shares

59,70,149 shares

Issue Size (Amount)

₹13.23 Crores

₹600.00 Crores

Buyback Ratio

Category	Entitlement Ratio of Buyback	Shares Offered
Reserved Category for Small Shareholders	1 Equity Shares out of every 2 Fully paid-up Equity Shares held on the Record Date.	945,000.00
General Category for all other Eligible Shareholders	1 Equity Shares out of every 5 Fully paid-up Equity Shares held on the Record Date.	5,355,000.00

Category	Entitlement Ratio of Buyback	Shares Offered
Reserved Category for Small Shareholders	6 Equity Shares out of every 67 Fully paid-up Equity Shares held on the Record Date.	895,523.00
General Category for all other Eligible Shareholders	2 Equity Shares out of every 395 Fully paid-up Equity Shares held on the Record Date.	5,074,626.00

Registrar

Niche Technologies Pvt. Ltd

Link Intime India Private Ltd

Lead Managers

Interactive Financial Services Ltd

ICICI Securities Limited

Necessity of the buyback

The Buyback is being undertaken for the following reasons:

The Buyback will help the Company to return surplus cash to its shareholders holding Equity Shares thereby, enhancing the overall return to shareholders;
The buyback will help the company to improve its capital structure by optimizing debt to equity ratio. It would also help improve financial ratios such as earnings per share and return on equity.
The buyback will give an option to the members holding equity shares of the company, who can choose to participate and get cash in lieu of equity shares to be accepted under the buyback offer or they may choose not to participate and enjoy a resultant increase in their percentage shareholding, post the buyback, without any additional investment.

The Buyback will help the company to distribute a part of the surplus cash to its shareholders holding equity shares thereby, optimizing returns to the shareholders and enhancing the overall shareholders' value in the longer term, and improving the return on equity.

Buyback Timetable

Arnold Holdings Buyback 2024 and Zydus Lifesciences Buyback 2024 buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Arnold Holdings Buyback 2024 Buyback record date is Jan 25, 2024. Zydus Lifesciences Buyback 2024 Buyback record date is Feb 23, 2024.

	Arnold Holdings Limited	Zydus Lifesciences Limited
Record Date	Jan 25, 2024	Feb 23, 2024
Offer Open Date	Feb 01, 2024	Feb 29, 2024
Offer Closure Date	Feb 07, 2024	Mar 06, 2024
Last date for receipt of tender forms	Feb 07, 2024	Mar 06, 2024
Finalisation of buyback	Feb 14, 2024	Mar 13, 2024
Last Date for settlment of bids	Feb 14, 2024	Mar 14, 2024
Last Date for extinguishment of shares	Feb 16, 2024	Mar 26, 2024

Financial Details and Other Relevent Information

Comparison of Arnold Holdings Buyback 2024 and Zydus Lifesciences Buyback 2024 financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.

Arnold Holdings Limited

Zydus Lifesciences Limited

Financial

Arnold Holdings Limited Financial Information (Restated Standalone)

Arnold Holdings Limited's revenue increased by 38.45% and profit after tax (PAT) rose by 152.56% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended	30 Sep 2023	31 Mar 2023	31 Mar 2022	31 Mar 2021
Assets		137.93	107.00	58.23
Revenue	89.83	164.61	118.90	37.48
Profit After Tax	1.66	3.81	1.51	0.69
Net Worth	59.36	57.70	54.23	53.05
Amount in ₹ Crore

Zydus Lifesciences Limited Financial Information (Restated Consolidated)

Zydus Lifesciences Limited's revenue increased by 17.07% and profit after tax (PAT) rose by 78.25% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended	31 Mar 2023	31 Mar 2022	31 Mar 2021
Revenue	9,553.50	8,160.60	7,869.30
Profit After Tax	1,529.20	857.90	1,476.20
Net Worth	17,515.80	16,999.60	12,992.30
Reserves and Surplus	1,801.75
Total Borrowing	1,163.20	4,196.00	4,583.50
Amount in ₹ Crore

Stock price at BSE

Stock price at BSE (in preceding 3 months)

Month	High Price	Low Price	Average Price
Dec-2023	26.10	16.90	22.28
Nov-2023	22.29	17.50	18.77
Oct-2023	19.50	16.90	18.44

Stock price at BSE (in preceding 3 months)

Month	High Price	Low Price	Average Price
Jan-2024	765.50	684.75	719.52
Dec-2023	696.65	630.15	657.86
Nov-2023	649.00	570.35	619.04

Stock price at NSE

Stock price at NSE (in preceding 3 months)

Month	High Price	Low Price	Average Price
Jan-2024	766.00	685.00	719.72
Dec-2023	696.50	630.00	658.11
Nov-2023	649.05	630.00	619.14

Compare with others

Arnold Holdings Limited	Zydus Lifesciences Limited
Shervani Industrial Syndicate Buyback 2024	Sharda Motor Industries Buyback 2024
Zydus Lifesciences Buyback 2024	Anand Rathi Buyback 2024
Freshtrop Fruits Buyback 2024	Dwarikesh Sugar Industries Buyback 2024
Orbit Exports Buyback 2024	Tips Industries Buyback 2024
Garware Technical Fibres Buyback 2024	Shervani Industrial Syndicate Buyback 2024
Bajaj Auto Buyback 2024	Freshtrop Fruits Buyback 2024
Chambal Fertilisers and Chemicals Buyback 2024	Orbit Exports Buyback 2024
Kaveri Seed Company Buyback 2024	Garware Technical Fibres Buyback 2024
Dhampur Sugar Mills Buyback 2024	Arnold Holdings Buyback 2024
SM Auto Stamping Buyback 2023	Bajaj Auto Buyback 2024

Comments

Add a public comment...